Expression and Role of the BDNF Receptor-TrkB in Rat Adrenal Gland under Acute Immobilization Stress by Kondo, Yusuke et al.
Acta Histochem. Cytochem. 43 (6): 139–147, 2010
doi:10.1267/ahc.10027
© 2010 The Japan Society of Histochemistry and Cytochemistry
Advance Publication
AHC Acta Histochemica et Cytochemica 0044-5991 1347-5800 Japan Society of Histochemistry and Cytochemistry Tokyo, Japan AHC10027 10.1267/ahc.10027 Regular Article
Expression and Role of the BDNF Receptor-TrkB in Rat Adrenal Gland under Acute 
Immobilization Stress
Yusuke Kondo*1,3, Juri Saruta*1,2,3, Masahiro To1,3, Naoto Shiiki1,3, Chikatoshi Sato1,3 
and Keiichi Tsukinoki1,3
1Department of Oral Pathology, Kanagawa Dental College Postgraduate School, Japan, 2Department of Craniofacial Growth and 
Development Dentistry, Division of Orthodontics, Kanagawa Dental College, Japan and 3Research Institute of Salivary Gland and 
Health Medicine, Kanagawa Dental College, Japan
Correspondence to: Keiichi Tsukinoki, D.D.S., Ph.D., Department of
Oral Pathology, Kanagawa Dental College Postgraduate School, 82
Inaoka-cho, Yokosuka, Kanagawa 238–8580, Japan. 
E-mail:  ktsukino@kdcnet.ac.jp
* Kondo Y. and Saruta J. equally contributed to this study.
?? Received September 9, 2010; accepted October 20, 2010; published online December 3, 2010
© 2010 The Japan Society of Histochemistry and Cy- We reported that plasma brain-derived neurotrophic factor (BDNF) was maximally elevated
following a 60-min period of acute immobilization stress and that salivary glands were the
main source of plasma BDNF under this stress condition. However, the expression pattern
of the BDNF receptor, Tyrosine receptor kinase B (TrkB), under this condition has yet to be
determined. We therefore investigated the effect of this stress on the expression level of
TrkB in various rat organs using real-time PCR. No significant differences were found
between controls and 60 min-stressed rats with respect to TrkB level in various organs. Only
adrenal glands showed significantly increased TrkB mRNA levels after 60 min of stress.
TrkB mRNA and protein were observed to localize in chromaffin cells. In addition, we inves-
tigated whether BDNF-TrkB interaction influences the release of stress hormones from PC12
cells, derived from chromaffin cells. Truncated receptor, TrkB-T1, was identified in PC12
cells using RT-PCR. Exposure of PC12 cells to BDNF induced the release of catecholamine.
This BDNF-evoked release was totally blocked by administration of the K252a in which
an inhibitor of Trk receptors. Thus, BDNF-TrkB interactions may modulate catecholamine
release from adrenal chromaffin cells under acute stress conditions.
Key words: acute immobilization stress, adrenal gland, brain-derived neurotrophic factor (BDNF),
Tyrosine receptor kinase B (TrkB)
I. Introduction
Brain derived neurotrophic factor (BDNF) belongs to
the neurotrophin family, which includes nerve growth factor
(NGF) as well as neurotrophin-3, -4/5, -6 and 7 [21]. The
members of this family exert their actions by binding to
two types of cellular membrane receptors named tyrosine
receptor kinase  family (Trk) and p75 neurotrophic receptor
(p75NTR) [26, 30, 42]. Moreover, there are three members of
the Trk receptor family, TrkA, TrkB and TrkC, which all
show different affinities for each neurotrophin [3, 8, 9].
For instance, TrkB has a specific affinity for BDNF [3]. In
rodents, alternative splicing of the mRNA that encodes TrkB
generates three distinct receptors: the full-length catalytic
receptor (TrkB FL), and two truncated forms, both of which
lack the intracellular tyrosine kinase domain (TrkBT1 and
T2) [23, 29, 41].
A high level of BDNF expression has been observed in
the central nervous system [4]. BDNF plays important roles
in the survival, differentiation, maintenance, and protection
from insults of neural cells [4, 16]. In the hippocampus,
BDNF has been shown to have an essential role in long-term
potentiation [11, 13, 19], and BDNF methionine (met) allele
of human subject is associated with poorer episodic memory
causing abnormal hippocampal activation [12]. BDNF is
also expressed in peripheral tissues such as lachrymalKondo et al. 140
glands, lymphocytes, macrophages and salivary glands and
is widely distributed in systemic organs [1, 22]. Most of
the neural effects of BDNF are mediated by binding to its
specific high-affinity receptor TrkB, through ligand-induced
dimerization, phosphorylation, and activation [4]. However,
the role of BDNF in peripheral tissues is not as well
understood.
In a previous ELISA analysis of human serum, Radka
et al. reported that serum BDNF values exceed 2.5 ng/ml,
and that plasma BDNF levels are approximately 50 pg/mL.
The mean BDNF value of rat serum is approximately 1
ng/mL, while the mean plasma level of BDNF is approxi-
mately 150 pg/mL [28]. The BDNF ELISA signal has little
or no level in either the serum or the plasma of mice [28].
Interestingly, low blood BDNF levels have been reported
in both schizophrenic patients and in patients with depres-
sive disorders [17]. A recent study of patients affected by
major depression reported that low plasma BDNF levels
may be a biological marker of suicidal depression [17]. Free
BDNF in plasma is assumed to indicate protection or main-
tenance of the neural cells that mediate TrkB activation
[40], since BDNF is able to pass through the blood-brain
barrier [27].
Our previous studies have shown that rat salivary
glands increase their expression of BDNF under acute stress
conditions [39]. Furthermore, the plasma level of BDNF is
increased by acute immobilization stress, and submandibu-
lar gland production of BDNF contributes to this increase
[40]. Indeed, the salivary glands are considered to be a pri-
mary source of plasma BDNF, and plasma BDNF concentra-
tion is greater in intact rats than in sialoadenectomized
rats [40]. These results suggest that BDNF produced by
the salivary glands may affect various organs under acute
immobilization stress [33]. In particular, maximal augmen-
tation of plasma BDNF level was observed 60 min after
immobilization stress exposure and was accompanied by an
increase in BDNF protein expression of the submandibular
gland [40]. However, the expression of TrkB at 60 min after
immobilization stress has not been investigated.
The first experiment of this study therefore analyzed
TrkB mRNA expression in systemic organs of a male rat
after 60 min of immobilization stress. The only organ that
showed increased TrkB expression was the adrenal gland.
We next analyzed the pattern of TrkB distribution in the
adrenal glands of rats under acute stress conditions using
in situ hybridization and immunohistochemical techniques
to identify TrkB-expressing cells. Interestingly, we showed
that TrkB mRNA and protein was localized in chromaffin
cells of the adrenal medulla. In the second part of the study,
we investigated whether BDNF-TrkB interaction influences
the release of stress hormones from PC12 cells, which are
derived from adrenal chromaffin cells. The aim of this part
of the study was to determine if BDNF-TrkB interactions of
the adrenal medulla influence stress reactions.
II. Materials and Methods
Experiment 1
Animals
Nine-week-old male Sprague-Dawley rats (Japan SLC,
Inc., Shizuoka, Japan) were used in this study. They were
housed in groups of six animals per cage in a room
maintained under standardized light (12:12-hr light-dark
cycle) and temperature (22±3°C) conditions. The animals
had free access to food pellets and tap water. To avoid
diurnal variations in TrkB expression, we sacrificed all rats
between 07:00 and 11:00.
Experimental procedures
All experiments were performed using four rats per
experimental group. On the first day of each experiment,
the animals were immobilized to produce acute stress in
accordance with a well-established protocol [39, 40]. Rats
were fixed on a wooden board (18×25 cm) in a supine
position by means of a leather belt, after which each of
their legs was fixed at an angle of 45° to the body midline
with adhesive tape. The rats were exposed to immobilization
stress for 60 min because this was the time at which the
plasma level of BDNF peaked in our previous studies [40].
Following selection of an organ that expresses TrkB mRNA
in response to stress, additional exposure times of 30 or 180
min were tested. The experimental protocol used in this
study was reviewed and approved by the Committee of
Ethics on Animal Experiments of Kanagawa Dental College
and was carried out in accordance with the Guidelines for
Animal Experimentation of Kanagawa Dental College.
RNA extraction and cDNA synthesis
Total RNA isolation was performed using the ISOGEN
reagent (Nippon Gene Co., Ltd., Toyama, Japan), in
accordance with the manufacturer’s instructions. RNA con-
centrations were determined by absorbance readings at
260 nm using a SmartSpec Plus spectrophotometer. Reverse
transcription was performed as outlined in the instruction
manual, using a first-strand cDNA synthesis kit (Roche
Diagnostics Ltd., Lewes, UK).
Real-time PCR
Real-time polymerase chain reactions (PCR) were
performed using rat tissues and a LightCycler system
(Roche) as previously described [34]. The primer sequences
used were: TrkB forward 5'-CACACACAGGGCTCCTTA-
3' and reverse 5'-AGTGGTGGTCTGAGGTTGG-3' (TrkB
PCR product: 169 bp) [20]. The β-actin primer sequences
were: 5'-CCTGTATGCCTCTGGTCGTA-3' (forward) and
5'-CCATCTCTTGCTCGAAGTCT-3' (reverse; PCR prod-
uct: 260 bp) [34]. The TrkB amplified region is the extra-
cellular domain (Pan-TrkB). The TrkB gene expression
level was expressed in terms of the copy number ratio of
TrkB to β-actin for each sample.TrkB Expression and Acute Stress 141
TrkB in situ hybridization (ISH)
Complementary RNA (cRNA) probes were produced
by in vitro transcription of linearized pGEM-T Easy Vectors
(Promega Co., WI, USA). Rat TrkB oligonucleotide primers
used were as described above. Digoxigenin (DIG)-11-UTP-
labeled single-stranded cRNA probes for rat TrkB were
prepared using the DIG labeling kit SP6/T7 (Roche) accord-
ing to the manufacturer’s instructions. Procedures for ISH
were as described previously [32]. ISH was performed using
3-μm tissue sections. Paraffin sections were digested with 1
μg/ml proteinase K for 20 min at 37°C. Hybridization was
performed at 50°C for 17 hr using DIG-11-UTP-labeled
single-stranded cRNA probes dissolved in hybridization
medium (Wako Pure Chemical Industries, Ltd., Tokyo,
Japan). After hybridization, mRNA was detected colorim-
etrically using a DIG-non-radioactive nucleic acid detection
kit (Roche).
Immunohistochemistry (IHC)
Resected rat tissue samples were fixed in 10% formalin
for 24 hr. IHC was performed using 3-μm sections. Immuno-
histochemical analysis was performed using Simple stain
MAX-PO, according to the instruction manual (Nichirei
Biosciences Inc., Tokyo, Japan). Sections were incubated
with anti-TrkB rabbit polyclonal antibody (sc-8316, 1:100,
Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) for
1 hr at room temperature. Non-immunized rabbit IgG was
used instead of primary antibody as a negative control. To
determine the specificity of the binding, a competitive assay
was also attempted using recombinant TrkB (R&D Systems,
Inc., Minneapolis, MN, USA).
Experiment 2 (PC12-based assays)
Cell line and BDNF/Trk inhibitor treatments
PC12 cells derived from chromaffin cells of the rat
adrenal medulla (DS Pharma Biomedical Co., Ltd., Osaka,
Japan) were seeded on collagen IV-coated culture dishes
(BD Biosciences, San Jose, CA, USA) and were cultured in
RPMI1640 (Invitrogen Corp., Carlsbad, CA, USA) supple-
ment with 10% fetal bovine serum (Thermo Fisher Scientific
Inc., Waltham, MA, USA) at 37°C under 5% CO2 [2].
Trk signaling of PC12 cells was blocked by the addi-
tion of 10 μg/ml K252a (Alomone Labs, Ltd., Jerusalem,
Israel), which is an inhibitor of tyrosine phosphorylation of
Trk receptors to the culture medium, for 5 min. The cells
were then stimulated with fresh medium containing 100
ng/ml recombinant BDNF (rBDNF, R&D Systems) for 5
min (K252a+rBDNF group). In other experiments, PC 12
cells were stimulated with culture medium containing 10
μg/ml K252a (K252a group) or 100 ng/ml rBDNF (rBDNF
group). For control experiments PC 12 cells were incubated
in medium without serum (control group).
Catecholamine assays
Catecholamines in the medium, such as adrenalin,
dopamine and noradrenalin, were analyzed after fraction-
ation by high performance liquid chromatography (HPLC).
The samples were passed through a cation exchange pre-
column to remove water soluble materials, and catechola-
mines were then separated using a HLC-8030 column (Toso
Co., Tokyo, Japan). The fluorescence produced by diphenyl-
ethylene-diamine and potassium ferricyanide was then
measured using an excitation wave length (λex) of 355 nm
and an emission wave length (λem) of 470 nm [31].
RT-PCR of PC12 cells
RNA extraction and cDNA synthesis protocols are as
described above. Reverse transcription-polymerase chain
reaction was performed using PC12 cells and TaKaRa Ex
Taq (Takara Bio Inc., Shiga, Japan). The primer sequences
used to amplify the full-length TrkB receptor (TrkB-FL)
were: forward, 5'-TGACGCAGTCGCAGATGCTG-3' and
reverse, 5'-TTTCCTGTACATGATGCTCTCTGG-3' (prod-
uct: 245 bp) (Invitrogen) [7]. The primer sequences for am-
plification of the truncated TrkB splice variant T1 (TrkB-
T1) were: forward, 5'-CGGGAGCATCTCTCGGTCT-3' and
reverse, 5'-AGGGGGATCTTATGAAACAAA-3' (PCR pro-
duct: 128 bp) (Invitrogen) [23]. The primers used to detect
the internal control marker GAPDH were: 5'-CCTTCATT
GACCTCAACTAC-3' (forward) and 5'-TTCACACCCAT
CACAAAC-3' (reverse PCR product: 306 bp) (Invitrogen).
The PCR and cycling conditions were: 94°C for 10 min
followed by 25 cycles of 94°C for 45 sec, 58°C for 30 sec
and 72°C for 45 sec for TrkB-FL [7]; and 94°C for 2 min
followed by 40 cycles of 94°C for 15 sec, 60°C for 30 sec
and 68°C for 30 sec for TrkB-T1 [23], and 98°C for 10 sec,
55°C for 30 sec, and 72°C for 1 min for 25 cycles for
GAPDH. PCR products were resolved by electrophoresis
in 3% agarose gels, stained with ethidium bromide, and
photographed using LAS3000 (Fuji Film Co., Tokyo,
Japan).
Immunocytochemistry
PC12 cells were incubated with medium containing
recombinant BDNF (100 ng/ml) for 5 min at 37°C. The
PC12 cells were then fixed with 4% paraformaldehyde for
5 min and air-dried. The cells were blocked in 10% rabbit
serum for 30 min at room temperature. These cells were next
incubated with anti-dopamine rabbit polyclonal antibody
(sc-11365, 1:50, Santa Cruz) or anti-noradrenalin rabbit
polyclonal antibody (ab8887, 1:50, Abcam, Cambridge,
MA, USA) in PBS for 1 hr at room temperature. After three
washes with PBS (5 min each), the cells were incubated in
PBS with polyclonal swine anti-rabbit immunoglobulins/
FITC (Dako Denmark A/S., Glostrup, Denmark) at a dilu-
tion of 1:100 for 1 hr at room temperature [37]. Immuno-
fluorescent signals were detected using Biozero BZ-8000
(Keyence Co., Osaka, Japan).
Statistical analysis
Statistical analyses were carried out using SPSS
Version 17.0 (SPSS, Inc., Chicago, IL, USA) and IGOR
Pro 6 (Wavemetrics, Lake Oswego, OR, USA) statistics pro-
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analysis of TrkB mRNA in various organs (expressed as
mean±SD) using SPSS. TrkB mRNA levels in adrenal
glands following immobilization stress were analyzed by
the Kruskal-Wallis test and, if significant, by the Nemenyi
test using IGOR Pro 6. Dopamine and noradrenalin that
were degranulated from PC12 cells were analyzed using
the Kruskal-Wallis test and, if significant, by multiple
comparisons using the Mann-Whitney U test and SPSS. P
values <0.05 were considered statistically significant.
III. Results
Quantitative analysis of TrkB mRNA in various rat organs
TrkB mRNA levels in rat organs were assayed using
real time-PCR. We first confirmed that the PCR product
thus obtained was TrkB mRNA. Melting curve analysis of
the RT-PCR product revealed a single fluorescent peak
representing the Tm (AQ) of TrkB mRNA in all samples,
except for the negative sample (data not shown). In addition,
a single RT-PCR product band was observed following
agarose gel electrophoresis (data not shown). TrkB/β-actin
mRNA ratios were calculated for the cerebral cortex,
pituitary gland, hippocampus, lung, stomach, liver, pan-
creas, adrenal gland, and kidney of control and 60 min
stressed rats. TrkB/β-actin ratios at 60 min and 0 min (non-
stressed) respectively were: 0.600±0.410 and 0.630±0.410
in the cerebral cortex; 0.374±0.140 and 0.331±0.380 in the
hippocampus; 0.177±0.075 and 0.112±0.042 in the lung;
0.003±0.001 and 0.004±0.001 in the stomach; 0.004±0.002
and 0.006±0.002 in the liver; 0.583±0.270 and 0.743±0.370
in the pancreas; and 0.005±5.00×10−4 and 0.004±2.00×10−4
in the kidney. No significant differences in TrkB/β-actin
ratios were found between control and 60 min-stressed rats
in these organs.
The respective 60 min and 0 min TrkB/β-actin ratios
were 0.420±0.090 and 3.400±0.740 in the pituitary gland,
and 4.740±1.870 and 1.430±0.390 in the adrenal gland. In
these organs there were significant differences in the TrkB/
β-actin ratios (p<0.05) between the control groups and the
Fig. 2. Localization of TrkB mRNA following immobilization stress. Representative photomicrographs show the expression and localization of
TrkB mRNA in paraffin-embedded adrenal tissues from immobilization-stressed rats. TrkB mRNA was detected by in situ hybridization using
an antisense TrkB cRNA probe. (A) TrkB mRNA in non-stressed rat adrenal gland. This tissue showed no hybridization signals in adrenal
cortex and medulla. (B) TrkB mRNA in 60 min-stressed rat adrenal gland. TrkB mRNA expression was observed in the adrenal medulla.
Open square shows inset. Bar=200 μm, 20 μm (inset).
Fig. 1. Analysis of TrkB mRNA levels using real time PCR. TrkB
mRNA levels in the adrenal gland of immobilization-stressed rats
was assayed using real time PCR. Data are expressed as TrkB/β-
actin mRNA ratios. TrkB mRNA levels were calculated as:
1.430±0.390 for non-stressed rats (0 min), and 3.330±0.950,
4.740±1.870, 3.700±1.180 for rats exposed to 30, 60 and 180 min,
respectively, of immobilization stress (n=6 for each group, error
bars: SEM). There were significant differences between non-
stressed and 30-, 60-, or 180-min stressed groups (*p<0.05).TrkB Expression and Acute Stress 143
60-min immobilization stress groups. However, expression
profile of TrkB mRNA in pituitary gland after acute stress
has been reported and our results were consistent with a
previous report [15].
Therefore, additional experiments were employed in
the adrenal gland. When the rats were exposed to immo-
bilization stress for 30, 60, or 180 min, the TrkB/β-actin
ratios in the adrenal gland were 3.330±0.950 at 30 min,
4.740±1.870 at 60 min, and 3.700±1.180 at 180 min (Fig. 1).
There were significant differences between the TrkB/β-actin
ratios of controls and of 60 min in immobilization stress
(p<0.05 for all comparisons).
TrkB in situ hybridization
We next analyzed the effect of immobilization stress on
TrkB mRNA levels in adrenal using in situ hybridization.
A high level of TrkB mRNA expression was detected in
positive control rat epididymal cells, but no signals were
seen in sections reacted with a sense probe (data not shown).
Little hybridization to the probe was observed in non-
stressed adrenal gland tissue, suggesting low, or no TrkB
mRNA expression (Fig. 2A). Furthermore, no TrkB mRNA
expression was detected in adrenal cortical cells in each of
the immobilization stress groups. However, intense TrkB
mRNA expression was observed in chromaffin cells of the
adrenal medulla after 60 min immobilization stress (Fig.
2B). Sense probes failed to show hybridization signals in
these cells (data not shown). Although erythrocytes showed
weak or strong positive-signals, these signals were con-
sidered to be non-specific staining.
TrkB immunohistochemistry
Immunohistochemical analysis of non-stressed adrenal
gland tissue revealed little or no expression of TrkB in
chromaffin cells of the adrenal medulla (Fig. 3A, asterisk
shows adrenal medulla). No TrkB expression was detected
in adrenal cortical cells in each of the immobilization stress
groups. However, weak TrkB expression was detected in
Fig. 3. Immunohistochemical localization of TrkB protein in adrenal tissue following immobilization stress. Representative photomicrographs
show the immunohistochemical localization of TrkB protein. (A) TrkB protein levels from non-stressed rat adrenal medulla. (B–D) TrkB-
expressing chromaffin cells of the adrenal medulla from the 30-min (B), 60-min (C), and 180-min (D) immobilization-stressed groups.
Bar=100 μm (*: adrenal medulla).Kondo et al. 144
chromaffin cells of the adrenal medulla after 30 or 180 min
of immobilization stress (Fig. 3B, D), and strong expression
was detected after 60 min of stress (Fig. 3C). Detection of
TrkB expression in stressed adrenal medulla was abolished
by competition with recombinant TrkB (data not shown).
Catecholamine levels
We next investigated if the BDNF-TrkB interaction
influences the release of stress hormones from PC12 cells
that are derived from adrenal chromaffin cells. The cells
were treated with the Trk inhibitor K252a and/or rBDNF
and released catecholamines were purified from the media.
Adrenalin was not detected in the media of any ex-
perimental group of cells. Dopamine levels of the different
groups were: K252a group, 2.96×102±0.39×102 pg/ml; rBD-
NF group, 3.44×103±1.18×103 pg/ml; K252a+rBDNF group,
2.83×102±1.22×102 pg/ml and control group, 3.80×102±1.02
×102 pg/ml. There was a significant difference between the
dopamine level of the rBDNF group and that of all other
groups (p<0.05 for all comparisons). There was no signifi-
cant different between the levels of the K252a+rBDNF
group and those of the control or the K252a group. The
dopamine level of the K252a+rBDNF group corresponded
to the control level (Fig. 4A).  Noradrenalin levels in the
media of the different treatment groups were: K252a group,
4.00±1.58 pg/ml; rBDNF group, 76.4±18.4 pg/ml; K252a+
rBDNF group, 4.60±2.30 pg/ml and control group: 5.00±
2.76 pg/ml. There was a significant difference between the
noradrenalin level of the rBDNF group and that of all other
groups (p<0.05 for all comparisons). There was no signifi-
cant difference between the K252a+rBDNF group and the
control or the K252a group. The noradrenalin level of the
K252a+rBDNF group corresponded to the control level
(Fig. 4B).
RT-PCR analysis of TrkB expression
We further analyzed TrkB isoform expression in the
PC12 cells using RT-PCR. Amplified products correspond-
ing to TrkB-T1 transcripts, but not products corresponding
to TrkB-FL, were detected (Fig. 5). An amplified fragment
of 306 bp, corresponding to a control GAPDH transcript,
was detected in both samples.
Fig. 4. Effect of BDNF-TrkB signaling on catecholamine secretion from PC12 cells. PC12 cells were treated with recombinant BDNF (rBDNF)
and/or the Trk inhibitor, K252a. The levels of dopamine (A) and adrenaline (B) in the media were then assayed using a fluorescent assay fol-
lowing their purification from the media. Dopamine levels were 2.96×102±0.39×102 pg/ml in the K252a, 3.44×103±1.18×103 pg/ml in the
rBDNF and 2.83×102±1.22×102 pg/ml in the K252a+ rBDNF groups and were 3.80×102±1.02×102 pg/ml in the control non-treated group (error
bars, SD). Noradrenaline levels were 4.00±1.58 pg/ml in the K252a, 76.4±18.4 pg/ml in the rBDNF and 4.60±2.30 pg/ml in the K252a+rBDNF
groups, and were 5.00±2.76 pg/ml in the control non-treated group (error bars, SD). Significant differences were observed between the
dopamine and the noradrenaline levels of the rBDNF group and those of each of the other groups (p<0.05 for all groups).
Fig. 5. RT-PCR analysis of the mRNA expression of TrkB isoforms
in PC12 cells. RT-PCR analysis detected mRNA expression of the
truncated TrkB-T1 isoform in PC12 cells but did not detect TrkB-
full length (TrkB-FL) mRNA. GAPDH mRNA was assayed as an
internal control.TrkB Expression and Acute Stress 145
Immunocytochemistry of catecholamines
To confirm that the higher catecholamine levels in
the media of PC12 cells treated with BDNF, reflected
depletion of intracellular catecholamine levels, we assayed
intracellular catecholamine levels using immunocytochem-
istry. PC12 cells were therefore treated with or without
BDNF, and were then incubated with anti-dopamine or
anti-noradrenalin antibodies, followed by incubation with an
FITC-labeled second antibody. In the non-BDNF-stimulated
PC12 cells FITC fluorescence, reflecting dopamine (Fig.
6A) or noradrenalin (data not shown) expression, was
observed in the cytoplasm, indicating that both of these
catecholamines are stored in the cytoplasm of PC12 cells. In
contrast, following administration of recombinant BDNF,
dopamine positive signals decreased in the cytoplasm (Fig.
6B), consistent with BDNF-induced release of dopamine
into the culture medium of PC12 cells. Although nor-
adrenalin expression patterns were similar to immuno-
cytochemical results of dopamine, noradrenalin signals were
lower than those for dopamine (data not shown).
IV. Discussion
In this paper, the TrkB mRNA level of organs including
cerebral cortex, hippocampus, lung, stomach, liver, pan-
creas, kidney, pituitary gland and adrenal gland were deter-
mined by real-time PCR using a primer set that recognizes
the TrkB extracellular domain (pan-TrkB). This screening
demonstrated that the TrkB mRNA level of cerebral cortex,
hippocampus, lung, stomach, liver, pancreas and kidney was
not affected by acute immobilization stress for 60 min
whereas the TrkB mRNA expression level of pituitary gland
and adrenal gland was modified. Interestingly, the latter two
organs are characterized by the production and release of
stress hormones. Furthermore, there is an intimate interplay
between the pituitary gland and the adrenal gland during
stress responses. Immobilization stress is known to up- or
down-regulate TrkB expression depending on the time
course of the stress, and the area of the brain that is assayed
[10, 15, 20, 25]. Our data were consistent with a previous
report that TrkB mRNA levels are decreased under im-
mobilization stress conditions in the rat pituitary gland
[15]. Givalois et al. suggested a novel physiological role of
BDNF as a hormonal factor in the endocrine response of
the pituitary gland to stress [15]. In addition, glucocorticoids
and other adrenal stress hormones may modulate pituitary
functions by regulating the expression of neurotrophic fac-
tors and its receptors [18]. Based on these previous reports
and our data, it was likely that there are interactions between
the pituitary and the adrenal gland that mediate neurotrophic
factors in stress conditions.
When the TrkB mRNA expression profile of rat adrenal
gland was investigated, the levels of TrkB mRNA were
significantly higher after 60 min of stress than in control
(non-stressed) rats, or in rats that were stressed for 30 or
180 min. No significant differences in TrkB mRNA levels
were observed between the control and the 30 or 180 min-
stressed groups. Schober et al. were the first to report that
neurotrophin-4, TrkA, and p75 are expressed in rat adrenal
medulla chromaffin cells in the absence of stress, but they
were unable to detect BDNF, NT-3, TrkB, or TrkC mRNA
by in situ hybridization using 35S-UTP-labeled cRNA probes
[35]. BDNF protein expression has been localized to the
subcapsular region of the rat adrenal cortex [36, 38]. In the
present paper, using multiple techniques, we demonstrated
increased expression of TrkB mRNA and protein in rat
adrenal gland tissue following stress. We also determined
that TrkB protein and mRNA are localized in chromaffin
cells of rat adrenal gland tissue. Our data indicate that TrkB
expression in the adrenal medulla following acute stress may
be important at 60 min of stress but not at later times because
TrkB mRNA levels had returned to control levels following
180 min of stress. Indeed, the time of the highest TrkB
expression following stress corresponds with the period
of time when the level of plasma BDNF is at its highest
following stress; i.e., at 60 min [40]. NGF has previously
been reported to exert its physiological role via the adrenal
gland following aggressive behavior [1]. Exogenous NGF
Fig. 6. Immunofluorescence analysis of the effect of BDNF on intracellular dopamine in PC12 cells. PC12 cells were either not treated (A) or
were treated (B) with 100 ng of BDNF for 5 min. Intracellular dopamine was then assayed using immunofluorescence. The lack of intracellular
dopamine expression in (B) indicated degranulation of the PC12 cells. Bar=30 μm.Kondo et al. 146
administration results in marked adrenal gland hypertrophy
[5] and blood NGF may target the adrenal gland [1]. Since
substances produced by the adrenal cortex pass from the
cortical artery into the adrenal medulla, BDNF produced by
the adrenal cortex may also interact with TrkB expressed on
the adrenal medulla. Thus, it is possible that blood BDNF, in
a similar manner to blood NGF, activates TrkB of adrenal
medulla during acute stress.
BDNF induced the release of catecholamines such as
noradrenalin and dopamine from PC12 cells, and this
BDNF-evoked release is completely blocked by the tyrosine
kinase inhibitor K252a. PC12 cells are a well established
cell line that is derived from adrenal medulla, but no
contains the adrenalin [14]. BDNF-evoked release of nor-
adrenalin and dopamine could be explained by TrkB activa-
tion. Most dopaminergic cells, including retinal cells, in a
wide range of species, express TrkB [24, 36]. In other areas
of the central nervous system, BDNF has been found to
induce the release of dopamine [6]. Truncated TrkB recep-
tors have dominant inhibitory effects on BDNF signaling in
cultured hippocampal neurons. However, in recent years, it
has been shown that the truncated TrkB receptor, TrkB-T1,
mediates neurotrophin-evoked calcium signaling in glial
cells and plays a direct signaling role in mediating inositol-
1,4,5-trisphoshate-dependent calcium release [29]. This sig-
naling pathway is consistent with the signaling mechanism
that mediates the release of dopamine, which involves an
increase in intracellular Ca2− levels in retinal amacrine cells
[24]. Clearly, PC12 cells have TrkB-T1 receptors, which
suggest that BDNF may induce the release of dopamine
by directly interacting with these receptors. Although PC12
cells do not express adrenalin, we believe that BDNF is
likely to play a role in the release of catecholamines, in-
cluding adrenalin, from adrenal tissue in vivo. We are
currently investigating the function of BDNF-TrkB inter-
action in adrenal medulla under conditions of acute im-
mobilization stress in vivo.
In summary, we present a number of novel findings
regarding the role of BDNF and its receptor TrkB during
immobilization stress. First, TrkB receptor expression was
increased under conditions of acute stress and was highest
at 60 min following stress in the adrenal medulla while
TrkB receptors are expressed under non-stressed conditions,
but at a lower level. Second, blood BDNF may activate
the TrkB receptors of adrenal medulla during acute stress.
Finally, BDNF directly induces the release of catechola-
mines from PC12 cells by activation of TrkB-T1 receptors.
Thus, BDNF-TrkB interactions may modulate catechola-
mine release from adrenal chromaffin cells under acute
stress conditions.
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